The vulnerable endothelium: priming the vascular endothelium for thrombosis with unfractionated heparin: biologic plausibility for observations from the Superior Yield of the New Strategy of Enoxaparin, Revascularization and GlYcoprotein IIb/IIIa Inhibitors (SYNERGY) trial.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Becker, RC

Published Date

  • August 2005

Published In

Volume / Issue

  • 150 / 2

Start / End Page

  • 189 - 192

PubMed ID

  • 16086916

Pubmed Central ID

  • 16086916

Electronic International Standard Serial Number (EISSN)

  • 1097-6744

Digital Object Identifier (DOI)

  • 10.1016/j.ahj.2005.04.006

Language

  • eng

Conference Location

  • United States